Analysis
Prothena FY25 Earnings Review: Partnered Programs Advance Toward Milestones as Wholly-Owned Assets Pivot
Business Overview Prothena Corporation plc operates as a late-stage clinical biotechnology company focusing predominantly on the science of protein dysregulation....